Alpha Tau receives ISO certification

Israeli radiation therapy technology developer Alpha Tau Medical said it has...Read more on AuntMinnie.comRelated Reading: Alpha Tau prepares clinical trials for Alpha DaRT
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

This study was carried out in accordance with the recommendations of international guidelines and ethical standards with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the Institutional Ethics Committee of Kunming General Hospital, China. miRNAs, Plasmids, Transfection, and Irradiation To predict miRNAs with potential binding sites in the 3′UTR of PHLDA2, Targetscan (http://www.targetscan.org/), miRanda (http://www.microrna.org/), and Diana database (http://diana.cslab,ece.nura.gr/) algorithms were u...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
CONCLUSIONExtensive EHE can be treated by radiation therapy and chemotherapy when surgery can’t be perfomed.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Condition:   Breast Cancer Intervention:   Radiation: Single Pre-Operative Radiation Therapy - with Delayed Surgery Sponsor:   Michael Yassa Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Intervention:   Device: AirXpanders AeroFormtissue expander Sponsor:   Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Intervention:   Radiation: Single Pre-Operative Radiation Therapy - with Delayed Surgery Sponsor:   Michael Yassa Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Intervention:   Device: AirXpanders AeroFormtissue expander Sponsor:   Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Device Technologies Australia to Help Expand Global MRIdian Adoption CLEVELAND, April 17, 2019 -- (Healthcare Sales &Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) and Device Technologies Australia Pty Ltd (Device Technologies) announced today a p... Devices, Oncology, Distribution ViewRay, Device Technologies, MRIdian, MRI-guided, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
Conclusions In the span of a very short time—less than a decade—robotic head and neck surgery has transformed the management of the head and neck cancer, and it seems clear that the future of treatment for these cancers lies in a multimodal approach in which TORS is likely to play an important role. Nevertheless, it is important to keep in mind that the current indications for TORS are limited and long-term data on the safety and oncological outcomes are needed to better understand the true role of TORS in treatment of head and neck cancer. Nonetheless, the emergence of ever more advanced robotic instruments i...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Many patients with endometrial cancer cannot undergo surgery and instead receive definitive radiation therapy (RT). We investigate the correlation between MRI response to RT and clinical outcomes.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
Conditions:   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-small Cell Lung Cancer Interventions:   Device: ViewRay MR-Linear Accelerator;   Radiation: Radiation therapy;   Drug: Paclitaxel;   Drug: Carboplatin AUC;   Biological: Durvalumab Sponsor:   Washington University School of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Israel Health | Radiation Therapy | Radiology